Brexanolone FDA approval date

The FDA approved Brexanolone (Allopregnanolone) on 19 Mar 2019.

FDA approval date
19 Mar 2019

Drug identity checked against registry records

Also recorded as Allopregnanolone; SAGE-547; ZULRESSO®

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-03-19DayBrexanoloneFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA211371", "applicant_as_listed_by_fda": "SAGE THERAP SUPERNUS", "brand_names": ["ZULRESSO"], "active_ingredients": ["BREXANOLONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190319", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026